A Randomized, Double-Blind, Controlled Clinical Study on the Curative Effect of Huaier on Mild-to-Moderate Psoriasis and an Experimental Study on the Proliferation of Hacat Cells

Table 1

The condition of the two groups before treatment.

	Yinxie Granule+HQH (treatment group) n=84	Yinxie Granule+placebo (control group) n=80
Age, years	32.2±10.7	33.4±11.2
Male,%	44	41
Female,%	40	39
Duration of the disease (month)	18.4	17.9
Psoriasis BSA involvement, %	6.90%±0.02%	6.75%±0.03%
sPGA Score, n(%)
2	43 (51.2)	40 (50.0)
3	39 (46.4)	37 (46.3)
4	2 (2.4)	3 (3.7)
DLQI score	9.4±6.2	9.2±6.9
PASI score	8.28±0.03	8.19±0.05

Data are presented as numbers (%) or the means ± standard deviations.
BSA: body surface area; sPGA: static physician's global assessment; DLQI: Dermatology Life Quality Index; PASI: Psoriasis Area and Severity Index. There was no significant difference between the experimental group and the control group (P>0.05).